Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. - Wikidata - awgldk - TriplyDB

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

http://www.wikidata.org/entity/Q37670311

about

The balance of powers: Redox regulation of fibrogenic pathways in kidney injury Calcium and ROS: A mutual interplay Redox signaling, Nox5 and vascular remodeling in hypertension NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells.Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.Endothelial Gata5 transcription factor regulates blood pressure.Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease Enzymatic regulation and functional relevance of NOX5 Oxidative stress and autophagy: crucial modulators of kidney injury Diabetes and Kidney Disease: Role of Oxidative Stress.NADPH oxidase in brain injury and neurodegenerative disorders Nox and renal disease.Nox5 stability and superoxide production is regulated by C-terminal binding of Hsp90 and CO-chaperones.APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.Are reactive oxygen species still the basis for diabetic complications?Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.Oxidative Stress and Hypertensive Diseases.Oxidative Stress in Atherosclerosis.Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways.NDRG2 contributes to cisplatin sensitivity through modulation of BAK-to-Mcl-1 ratio.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.NADPH Oxidase 5 Is a Pro-Contractile Nox Isoform and a Point of Cross-Talk for Calcium and Redox Signaling-Implications in Vascular Function

P2860

Q26786137-85B41A0A-05CC-4A4E-961C-1B407BD6912B Q26795721-AB78FA21-CC47-44CE-8432-6C64DF74DB0A Q26801400-C8B045F0-4C3A-49FF-9779-5EFAD6305125 Q33775852-0311B9ED-6D1B-4479-B642-6D60477373C8 Q34631886-325B3D11-BD23-485B-BE42-1C9F0D2D3C06 Q35200898-BCAA11CF-5338-4328-9790-8AA14BA660FF Q35450699-1D0B119B-7BA4-467E-9AB1-2C29F506C124 Q35671828-F30AD595-4C39-4F48-B1D2-B43995092007 Q36417731-25E9A91A-C2A4-4DCC-8919-24703B603C94 Q36514979-1B9183AE-B8B4-4F91-AD9F-01AB5B4712B0 Q36574640-27BB7437-AFC9-4A14-B460-B9882B258A19 Q36717785-3717C7CC-80A5-4140-AE0D-9B5D3FB9B567 Q37349206-48802B82-1B6F-4741-B8DD-F05A74952199 Q37589114-24E50544-1CC3-40DA-995D-77CC299428E4 Q38335626-D1BC4FB7-CB9A-495E-AB34-1666F72FE243 Q38382136-2C37D778-00DC-4EB4-8CB8-55DDE7E971BC Q38406031-13E3BECC-9816-47F9-893D-62259AA2C740 Q38451253-D64F4549-9E5B-4025-9028-9B80E2F5E21E Q38843567-E828813E-5FA0-4FFA-AF30-118AF1850E14 Q39018896-ABE22FE1-85DB-4D84-A073-0F727045B075 Q46305239-30D2EC97-B643-4B3D-8357-1179349C128D Q46648044-ECEA120E-9F80-46CF-B164-9E917AA8FFFE Q46819734-4E2BEDD4-9232-4E9F-9591-3A1781046D74 Q48215735-2E2B7774-DBC7-4744-927A-1798DD9B613B Q49833824-AA722AC5-41AF-40BA-AE31-7DD2725DA220 Q52674866-A5B4F391-EB12-4A14-8E0D-7AE12631F313 Q54956778-30C6D6DB-E7A1-4BCB-9A82-9B0195A1B931 Q58869233-CE1EF34B-5B7D-40E2-BB56-607E19AEF445

P2860

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

http://www.wikidata.org/entity/Q37670311

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@en

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@nl

type

label

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@en

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@nl

prefLabel

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@en

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@nl

P1433

Q37670311-638B70E9-01FC-4F0E-B997-72326A39DC7B

P1476

Q37670311-3ADCF99F-05B2-48B1-B4B6-7944936AAFFE

P2093

Q37670311-0ED472B8-7451-473B-9176-48613058A8D9

Q37670311-21C998CA-817D-457B-8A0B-B0B13A3D9AF4

Q37670311-3C8FCEFA-0315-48EA-808C-1FBF9862A719

Q37670311-4BBDB6A7-D170-41BE-AC11-D6E3F949C440

Q37670311-6014A379-5944-4097-85FF-12581A238EDD

Q37670311-9ED97331-9933-4DD6-8846-86CC86F97470

Q37670311-FF0A9156-BF4E-4830-BB4F-BA25C7117186

P2860

Q37670311-00BE66BC-354C-48D7-8B7F-EF97E83CE708

Q37670311-0BA4E564-F656-4241-9A96-B90002DAC311

Q37670311-0BE61F24-0AA6-42EE-8DB6-17EF8E15A459

Q37670311-0CB73868-24F0-4F02-9F87-113B0D1E4B36

Q37670311-0E124635-B2EE-4E43-9446-73241FEF2365

Q37670311-0E33AD99-7A99-4775-B37D-E117533246A9

Q37670311-14F1012B-4ED5-49AB-9DB1-76ECE42357DD

Q37670311-17C54D7F-F683-40A2-9C41-A9DB09765095

Q37670311-18A1D3A2-14CA-466F-853B-8E8E018B86BF

Q37670311-271F9617-7D1F-43CD-A9AD-007672067D4A

P304

Q37670311-8EE34F43-C08A-45AD-8777-7D6992D2F4E6

P31

Q37670311-9EE54F95-4478-4AAD-A00B-F71280E03CE2

P356

Q37670311-0DBED9B0-ED4D-4F4D-87C4-6CEADC0487B9

P433

Q37670311-E16CEDEB-5B1D-4896-949F-83B7B69B584C

P478

Q37670311-C3D35B79-036F-4BA0-9876-0908C99CA83E

P50

Q37670311-2BE91081-46E0-43A0-839B-EC6F51FA941C

Q37670311-9F73A7BA-D808-4D04-B47C-F133E7FC97D7

P577

Q37670311-4836A1D1-922D-4FF9-8A87-68132C992FA8

P698

Q37670311-60E930E5-F4F1-4A0D-874F-DB80D1EF1B70

P932

Q37670311-F41D20D8-3608-432E-B923-72BD3C499C06

P356

P1433

Journal of the American Society of Nephrology

P1476

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.

@en

P2093

Alex Gutsol

http://www.w3.org/2001/XMLSchema#string

Augusto C Montezano

http://www.w3.org/2001/XMLSchema#string

Chelsea Towaij

http://www.w3.org/2001/XMLSchema#string

Christopher R J Kennedy

http://www.w3.org/2001/XMLSchema#string

Jean-François Thibodeau

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Robin J Parks

http://www.w3.org/2001/XMLSchema#string

P2860

NOX5 variants are functionally active in endothelial cells

NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells

Activation of a local tissue angiotensin system in podocytes by mechanical strain.

Mouse models of diabetic nephropathy.

Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5.

Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5).

P304

784-797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013040371

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Chet E Holterman

P577

2013-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24262797

http://www.w3.org/2001/XMLSchema#string

P932

3968494

http://www.w3.org/2001/XMLSchema#string